Dow Up 0.08% Nasdaq Down 0.30%

Celsion Corp. (CLSN)

-NCM
3.03 Down 0.05(1.62%) Sep 19, 4:00PM EDT
Prev Close:3.08
Open:3.07
Bid:2.10 x 200
Ask:N/A
1y Target Est:8.00
Beta:2.11
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:3.00 - 3.09
52wk Range:2.82 - 5.90
Volume:63,267
Avg Vol (3m):115,133
Market Cap:60.47M
P/E (ttm):N/A
EPS (ttm):-0.85
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLSN

Comparison

Symbol% ChgMkt Cap
CLSNDown 1.62%60.47M
BSDMDown 5.36%22.42M
DCTHDown 4.80%20.59M
MMSIDown 2.73%538.62M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):122.94
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.33
Quarterly EPS Est (Sep-14) :-0.32
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback